Institutional investors purchased a net $3.9 million shares of AVEO during the quarter ended June 2014 and now own 42.10% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FORE RESEARCH & MANAGEMENT LP Bought 674.2 Thousand shares of Aveo Pharmaceuticals Inc
GRUSS CAPITAL MANAGEMENT LP Bought 533.3 Thousand shares of Aveo Pharmaceuticals Inc